Caplin Point Lab

{
  "main_header": {
    "sid": 640544,
    "name": "Caplin Point Lab",
    "stock_name": "Caplin Point Lab",
    "full_name": "Caplin Point Laboratories Ltd",
    "name_url": "stocks-analysis/caplin-point-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,602.40",
    "chg": 13.15,
    "chgp": "0.51%",
    "dir": 1,
    "prev_price": "2,589.25",
    "mcapval": "19,781.28 Cr",
    "mcap": "Small Cap",
    "scripcode": 524742,
    "symbol": "CAPLIPOINT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE475E01026",
    "curr_date": "Jul 29, 11:08 AM",
    "curr_time": "11:09 AM",
    "last_traded_at": "Jul 29, 11:08 AM IST",
    "bse_nse_vol": "32.47 k",
    "exc_status": "Active",
    "traded_date": "Jul 29, 2026",
    "traded_date_str": "2026 07 29",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caplin-point-lab-640544-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Caplin Point Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4123644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_mojoScore_4123644.png",
        "date": "2026-07-28 08:40:16",
        "description": "Caplin Point Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 27 Jul 2026, highlights the company’s robust quarterly performance, bullish technical signals, and sustained shareholder returns, positioning it favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Caplin Point Laboratories Ltd Surges 7.48% to Day's High of Rs 2638.95 — Outperforms Sector by 5.42 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-intraday-high-with-748-surge-on-27-jul-2026-4122789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_priceRelatedfactors_4122789.png",
        "date": "2026-07-27 14:47:32",
        "description": "The Sensex advanced 1.03% on 27 Jul 2026, yet Caplin Point Laboratories Ltd outpaced the broader market with a robust 7.48% gain, reaching an intraday high of Rs 2638.95. This 5.42-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Caplin Point Laboratories Declines 5.71%: Mixed Technical Signals Shape Weekly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-declines-571-mixed-technical-signals-shape-weekly-performance-4120933",
        "imagepath": "",
        "date": "2026-07-26 09:01:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> Stock opens strong at Rs.2,647.75 (+1.29%) despite flat Sensex</p>\n                    <p><strong>22 Jul:</strong> Mojo Grade downgraded to Hold amid mixed technical and valuation signals</p>\n                    <p><strong>23 Jul:</strong> Technical momentum shifts to bullish despite 4.84% price drop</p>\n                    <p><strong>24 Jul:</strong> Week closes at Rs.2,464.65, down 0.90% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,614.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Wee..."
      },
      {
        "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicators-4116996",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_technicaldot_4116996.png",
        "date": "2026-07-23 08:02:36",
        "description": "Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend despite a recent decline in price. The stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish cues from the monthly RSI and KST. This article analyses these technical parameters in detail, placing the stock’s performance in context with broader market movements and its historical returns."
      },
      {
        "title": "Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4114644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_mojoScore_4114644.png",
        "date": "2026-07-22 08:22:42",
        "description": "Caplin Point Laboratories Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 21 July 2026. This adjustment reflects a nuanced reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite strong financial performance and consistent returns, evolving technical indicators and valuation concerns have tempered the outlook, prompting a more cautious stance among investors."
      },
      {
        "title": "Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4114403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_technicaldot_4114403.png",
        "date": "2026-07-22 08:01:52",
        "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment."
      },
      {
        "title": "Caplin Point Laboratories Gains 1.11%: 6 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-gains-111-6-key-factors-driving-the-week-4107521",
        "imagepath": "",
        "date": "2026-07-18 16:05:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Jul:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>14 Jul:</strong> Mojo Grade upgraded to Buy; technical trend turns bullish</p>\n                    <p><strong>15 Jul:</strong> New 52-week and all-time high at Rs.2,700; record quarterly results announced</p>\n                    <p><strong>17 Jul:</strong> Week closes at Rs.2,614.00, up 1.11% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,585.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Caplin Point Laboratories Ltd to 52-Week High of Rs 2700",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-new-52-week-high-at-rs2700-4103417",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_priceRelatedfactors_4103417.png",
        "date": "2026-07-15 09:46:26",
        "description": "With every major technical indicator aligned to the upside, Caplin Point Laboratories Ltd surged to a fresh 52-week and all-time high of Rs 2700 on 15 Jun 2026, marking a significant milestone in its price momentum journey."
      },
      {
        "title": "Caplin Point Laboratories Ltd Hits All-Time High of Rs 2,700 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-hits-all-time-high-at-rs-2700-4103383",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CaplinPointLabo_priceRelatedfactors_4103383.png",
        "date": "2026-07-15 09:32:41",
        "description": ""
      }
    ],
    "total": 663,
    "sid": "640544",
    "stock_news_url": "https://www.marketsmojo.com/news/No announcements on  in the last one month-640544"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "11-Jul-2026",
      "details": "Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Jun-2026",
      "details": "Intimation of closure of Trading Window commencing from July 01 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "22-Jun-2026",
      "details": "Newspaper advertisement for transfer of Unclaimed dividend and shares to IEPF",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16",
          "dt": "2016-10-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Caplin Point Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-07-28 08:40:16

Caplin Point Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 27 Jul 2026, highlights the company’s robust quarterly performance, bullish technical signals, and sustained shareholder returns, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Caplin Point Laboratories Ltd Surges 7.48% to Day's High of Rs 2638.95 — Outperforms Sector by 5.42 Percentage Points

2026-07-27 14:47:32

The Sensex advanced 1.03% on 27 Jul 2026, yet Caplin Point Laboratories Ltd outpaced the broader market with a robust 7.48% gain, reaching an intraday high of Rs 2638.95. This 5.42-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Caplin Point Laboratories Declines 5.71%: Mixed Technical Signals Shape Weekly Performance

2026-07-26 09:01:54

Key Events This Week

20 Jul: Stock opens strong at Rs.2,647.75 (+1.29%) despite flat Sensex

22 Jul: Mojo Grade downgraded to Hold amid mixed technical and valuation signals

23 Jul: Technical momentum shifts to bullish despite 4.84% price drop

24 Jul: Week closes at Rs.2,464.65, down 0.90% on the day

Week Open

Rs.2,614.00

Wee...

Read full news article

Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-07-23 08:02:36

Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend despite a recent decline in price. The stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish cues from the monthly RSI and KST. This article analyses these technical parameters in detail, placing the stock’s performance in context with broader market movements and its historical returns.

Read full news article

Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-07-22 08:22:42

Caplin Point Laboratories Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 21 July 2026. This adjustment reflects a nuanced reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite strong financial performance and consistent returns, evolving technical indicators and valuation concerns have tempered the outlook, prompting a more cautious stance among investors.

Read full news article

Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-07-22 08:01:52

Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment.

Read full news article

Caplin Point Laboratories Gains 1.11%: 6 Key Factors Driving the Week

2026-07-18 16:05:23

Key Events This Week

13 Jul: Technical momentum shifts amid mixed indicator signals

14 Jul: Mojo Grade upgraded to Buy; technical trend turns bullish

15 Jul: New 52-week and all-time high at Rs.2,700; record quarterly results announced

17 Jul: Week closes at Rs.2,614.00, up 1.11% for the week

Week Open

Rs.2,585.40

Week Close...

Read full news article

Broad-Based Technical Strength Lifts Caplin Point Laboratories Ltd to 52-Week High of Rs 2700

2026-07-15 09:46:26

With every major technical indicator aligned to the upside, Caplin Point Laboratories Ltd surged to a fresh 52-week and all-time high of Rs 2700 on 15 Jun 2026, marking a significant milestone in its price momentum journey.

Read full news article

Caplin Point Laboratories Ltd Hits All-Time High of Rs 2,700 as Momentum Builds Across Timeframes

2026-07-15 09:32:41

Read full news article

View All News